Format for Printing from Your Browser, MS-Word, LaTeX, rich LaTeX

Curriculum vitae

Department/Faculty/University
  • Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, School of Medicine
Function, current position
  • Medical Oncology Specialist (Division of Solid Tumor Oncology), Associate Professor
Education and academic qualifications
  • 2016: Associate Professor of Oncology
  • 2015: ESMO Examination in Medical Oncology
  • 2009-2014: Specialty Training in Medical Oncology
  • 2010-2012: Ph.D. in Oncology
    Thesis: "New diagnostic and therapeutic methods in selected rare hematooncological diagnoses"
  • 2003-2009: M.D. in General Medicine (passed with honours)
Professional experience
  • Since 2010: Lecturer
    Masaryk University, School of Medicine
  • Since 2009: Physician
    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno
Teaching activities
  • Internal Medicine, Oncology
Academic activities
  • 90 scientific publications (of which 41 as the first author)
  • 57 cumulative impact factor
  • 175 citations
  • Projects:
    Evaluation of MET Expression and Inhibition in Squamous Cell Carcinomas of the Head and Neck (ESMO)
    Register of Very Rare Hematooncologic Diseases in Adult Patients (SUp FNB 2/14)
    Internet Portal for Very Rare Hematologic and Oncologic Diseases (23/14/NAP)
Internship and stays for the purpose of study or work
  • 2015-2016: ESMO Translational Research Fellowship at the Bichat-Beaujon University Hospital in Paris, France
  • 2014: ESMO Clinical Unit Visit fellowship at the Antwerp University Hospital in Belgium
  • 2007-2008: Medical University of Vienna and the Vienna General Hospital, Austria under the Socrates/Erasmus programme
  • 2007: Kliniken Erlabrunn in Germany (surgery, internal medicine)
Research interests
  • Head & Neck Cancer
  • Translational Research
  • Very Rare Diseases - Histiocytic disorders, Castleman disease, Skin manifestations of monoclonal gammopathies, Vasculopathies
Professional Society Memberships
  • European Society for Medical Oncology
  • Czech Society of Internal Medicine
  • Czech Society for Oncology
  • Czech Society of Hematology
Awards Related to Science and Research
  • 2013: Young Investigators' Award during the DGHO 2013 Congress in Vienna
  • 2013: 1st place for the best original article in 2012 from the Czech Society of Internal Medicine
  • 2011: Paul Janssen Award for the most outstanding publication contribution to multiple myeloma
Peer-reviewed journals with IF (first or corresponding author):
  • SZTURZ, Petr; E. RAYMOND and S. FAIVRE. c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside. Oral oncology. AMSTERDAM: ELSEVIER SCIENCE BV, 2016, vol. 59, AUG 2016, p. "E12"-"E14", 3 pp. ISSN 1368-8375. Available from: https://dx.doi.org/10.1016/j.oraloncology.2016.05.017. URL info
  • SZTURZ, Petr; Pol SPECENIER; Carl VAN LAER; Danielle VAN DEN WEYNGAERT; Bob CORTHOUTS; Laurens CARP; Eric VAN MARCK; Olivier VANDERVEKEN and Jan B. VERMORKEN. Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab. European Archives of Oto-Rhino-Laryngology and Head & Neck. NEW YORK: SPRINGER, 2016, vol. 273, No 6, p. 1629-1636. ISSN 0937-4477. Available from: https://dx.doi.org/10.1007/s00405-015-3673-y. info
  • SZTURZ, Petr and S. FAIVRE. Letter to the editor referring to the publication entitled “The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment” by Pai et al. Oral Oncology. Amsterdam: Elsevier Science BV, 2016, vol. 62, "neuvedeno", p. "e3"-"e4", 2 pp. ISSN 1368-8375. Available from: https://dx.doi.org/10.1016/j.oraloncology.2016.08.007. info
  • ŘEHÁK, Zdeněk and Petr SZTURZ. Comment on: FDG PET in the early diagnosis of large-vessel vasculitis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER, 2014, vol. 41, No 3, p. 579-580. ISSN 1619-7070. Available from: https://dx.doi.org/10.1007/s00259-013-2662-x. info
  • ŘEHÁK, Zdeněk; Petr SZTURZ; Leoš KŘEN; Zdeněk FOJTÍK and Jaroslav STANÍČEK. Upsampling from aorta and aortic branches: PET/CT hybrid imaging identified 18F-FDG hypermetabolism in inflamed temporal and occipital arteries (Upsampling From Aorta and Aortic Branches PET/CT Hybrid Imaging Identified F-18-FDG Hypermetabolism in Inflamed Temporal and Occipital Arteries). CLINICAL NUCLEAR MEDICINE. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2014, vol. 39, No 1, p. "e84"-"e86", 3 pp. ISSN 0363-9762. Available from: https://dx.doi.org/10.1097/RLU.0b013e3182868aae. info
  • SZTURZ, Petr. Very rare diseases in oncology. Medical oncology. Totowa: HUMANA PRESS INC, 2014, vol. 31, No 5, p. 947-948. ISSN 1357-0560. Available from: https://dx.doi.org/10.1007/s12032-014-0947-y. info
  • SZTURZ, Petr; Zdeněk ADAM; Z. ŘEHÁK and Renata KOUKALOVÁ. Xanthelasma palpebrarum responding to interleukin-1 blockade. Internal medicine journal. Hoboken: Wiley-Blackwell, 2014, vol. 44, No 6, p. 617-618. ISSN 1444-0903. Available from: https://dx.doi.org/10.1111/imj.12441. info
  • SZTURZ, Petr; M. PRÁŠEK; Z. ŘEHÁK and P. FABIAN. Unicentric Castleman disease: from screening mammography to PET/CT imaging. Nuklearmedizin-Nuclear Medicine. Stuttgart: Schattauer GmbH-Verlag Medizin Naturwissenschaften, 2014, vol. 53, No 5, p. "N41"-"N43", 3 pp. ISSN 0029-5566. info
  • SZTURZ, Petr; Zdeněk ADAM; Vladimír VAŠKŮ; Josef FEIT; Marta KREJČÍ; Luděk POUR; Roman HÁJEK and Jiří MAYER. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2013, vol. 54, No 6, p. 1324-1326. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2012.738816. info
  • SZTURZ, Petr; Libor HLAVATÝ; Jiří PRÁŠEK and Dana DVOŘÁKOVÁ. Erdheim-Chester disease and Schnitzler syndrome: so near, and yet so far. USA: Springer, 2013. Available from: https://dx.doi.org/10.1007/s12185-013-1437-2. info
  • ADAM, Zdeněk; Petr SZTURZ; Jiří VANÍČEK; Mojmír MOULIS; Luděk POUR; Marta KREJČÍ; Roman HÁJEK and Jiří MAYER. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. Acta Oncologica. LONDON: INFORMA HEALTHCARE, 2013, vol. 52, No 5, p. 994-1001. ISSN 0284-186X. Available from: https://dx.doi.org/10.3109/0284186X.2012.716164. info
  • SZTURZ, Petr; Zdeněk ADAM; Zdenek REHAK; Renata KOUKALOVÁ; Leoš KŘEN; Mojmír MOULIS; Marta KREJČÍ and Jiří MAYER. Salvage lenalidomide in four rare oncological diseases. Tumori. Roma: PENSIERO SCIENTIFICO EDITOR, 2013, vol. 99, No 5, p. "e251"-"e256", 6 pp. ISSN 0300-8916. Available from: https://dx.doi.org/10.1700/1377.15326. URL info
  • SZTURZ, Petr; Zdeněk ADAM; Zdeněk ŘEHÁK; Renata KOUKALOVÁ; Radka ŠLAISOVÁ; Olga STEHLÍKOVÁ; Jana CHOVANCOVÁ; Martin KLABUSAY; Marta KREJČÍ; Luděk POUR; Roman HÁJEK and Jiří MAYER. Lenalidomide proved effective in multisystem Langerhans cell histiocytosis. Acta Oncologica. 2012, vol. 51, No 3, p. 412-415. ISSN 0284-186X. Available from: https://dx.doi.org/10.3109/0284186X.2011.631581. info
  • SZTURZ, Petr; Zdeněk ŘEHÁK; Renata KOUKALOVÁ; Zdeněk ADAM; Marta KREJČÍ; Luděk POUR; Lenka ZAHRADOVÁ; Jiří VANÍČEK; Tomáš NEBESKÝ; Roman HÁJEK and Jiří MAYER. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma. Nuclear Medicine and Biology. 2012, vol. 39, No 3, p. 429-436. ISSN 0969-8051. Available from: https://dx.doi.org/10.1016/j.nucmedbio.2011.10.002. info
  • ŘEHÁK, Zdeněk; Petr SZTURZ; Eva KREJČÍ and Ilona KOCÁKOVÁ. FDG-PET-Positive Foreign-Body Granuloma Mimicking Residual Germinal Tumor Infiltration. Clinical Nuclear Medicine. 2012, vol. 37, No 8, p. 790-792. ISSN 0363-9762. Available from: https://dx.doi.org/10.1097/RLU.0b013e3182485291. info
  • SZTURZ, Petr; Zdeněk ADAM; Jana CHOVANCOVÁ; Olga STEHLÍKOVÁ; Martin KLABUSAY; Josef FEIT; Leoš KŘEN; Zdeněk FOJTÍK; Marta KREJČÍ; Luděk POUR; Roman HÁJEK and Jiří MAYER. Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease. Leukemia & Lymphoma. LONDON: INFORMA HEALTHCARE, 2012, vol. 53, No 4, p. 743-745. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2011.627482. info
  • SZTURZ, Petr; Zdeněk ADAM; Jana CHOVANCOVÁ; Olga STEHLÍKOVÁ; Martin KLABUSAY; Z. ŘEHÁK; R. KOUKALOVÁ; Lenka ZAHRADOVÁ; Marta KREJČÍ; Luděk POUR; Roman HÁJEK and Jiří MAYER. Lenalidomide: a new treatment option for Castleman disease. Leukemia & Lymphoma. LONDON: INFORMA HEALTHCARE, 2012, vol. 53, No 10, p. 2089-2091. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2011.621564. info
  • SZTURZ, Petr; Zdeněk ADAM; Roman HÁJEK and Jiří MAYER. Successful Anakinra Therapy in 2 Patients with Schnitzler Syndrome. Onkologie. Switzerland: Karger, 2011, vol. 34, No 5, p. 265-268. ISSN 0378-584X. Available from: https://dx.doi.org/10.1159/000327816. URL info
  • SZTURZ, Petr; Zdeněk ADAM; Mária KLINCOVÁ; Josef FEIT; Marta KREJČÍ; Luděk POUR; Lenka ZAHRADOVÁ; Vladimír VAŠKŮ; Roman HÁJEK and Jiří MAYER. Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen. Clinical Lymphoma, Myeloma & Leukemia. 2011, vol. 11, No 6, p. 517-520. ISSN 2152-2650. Available from: https://dx.doi.org/10.1016/j.clml.2011.06.014. info

2016/09/04


Curriculum vitae: doc. MUDr. Petr Szturz, Ph.D. (učo 101717), version: English(1), last update: 2016/09/04 19:47, P. Szturz